The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency

Human Reproduction

Volumn 29, Issue 7, 2014, Pages 1585-1593

  Voorhuis, M ^a   Onland Moret, N C ^a   Janse, F ^a   Ploos Van Amstel, H K ^a   Goverde, A J ^a   Lambalk, C B ^b   Laven, J S E ^c   Van Der Schouw, Y T ^a   Broekmans, F J M ^a   Fauser, B C J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CGG repeats; fragile X mental retardation gene 1; menopause; ovarian ageing; primary ovarian insufficiency

Indexed keywords

CYTOSINE; FRAGILE X MENTAL RETARDATION PROTEIN; GUANINE; FMR1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FRAGILE X SYNDROME; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION SYSTEM; PREMATURE OVARIAN FAILURE; SENESCENCE; ADOLESCENT; COHORT ANALYSIS; GENETICS; METABOLISM; MIDDLE AGED; PROGNOSIS; RISK; TRINUCLEOTIDE REPEAT; YOUNG ADULT;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; MENOPAUSE; MIDDLE AGED; ODDS RATIO; PRIMARY OVARIAN INSUFFICIENCY; PROGNOSIS; TRINUCLEOTIDE REPEAT EXPANSION; TRINUCLEOTIDE REPEATS; YOUNG ADULT;

EID: 84902682645     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu095     Document Type: Article

References (54)

1. Allen EG, He W, Yadav-Shah M, Sherman SL. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet 2004;114:439-447.
2. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, Charen K, He W, Taylor KC, Sherman SL. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod 2007;22:2142-2152.
3. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A et al. FragileXpremutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet 1999;83:322-325.
4. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion. No. 338: Screening for Fragile X Syndrome. Obstet Gynecol 2006;107:1483-1485.
5. Bachelot A, Rouxel A, Massin N, Dulon J, Courtillot C, Matuchansky C, Badachi Y, Fortin A, Paniel B, Lecuru F et al. ; POF-GIS Study Group. Phenotyping and genetic studies of 357 consecutive patients presenting Premature Ovarian Failure. Eur J Endocrinol 2009;161:179-187.
6. Bennett CE, Conway GS, Macpherson JN, Jacobs PA, MurrayA. Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Hum Reprod 2010;25:1335-1338.
7. Bretherick KL, Fluker MR, RobinsonWP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117:376-382.
8. Bodega B, Bione S, Dalpra L, Toniolo D, Ornaghi F, Vegetti W, Ginelli E, Marozzi A. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 2006;21:952-957.
9. Boker LK, van Noord PA, van der Schouw YT, Koot NV, Bueno de Mesquita HB, Riboli E, Grobbee DE, Peeters PH. Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol 2001;17:1047-1053.
10. Chang SH, Kim CS, Lee KS, Kim H, Yim SV, Lim YJ, Park SK. Premenopausal factors influencing premature ovarian failure and early menopause. Maturitas 2007;58:19-30.
11. Chen SH, Schoof JM, Buroker NE, Scott CR. The identification of a (CGG)6AGG insertion within the CGG repeat of the FMR1 gene in Asians. Hum Genet 1997;99:793-795.
12. Christin-Maitre S, Tachdjian G. Genome-wide association study and premature ovarian failure. Ann Endocrinol (Paris) 2010;71:218-221.
13. Cooper AR, Baker VL, Sterling EW, Ryan ME, Woodruff TK, Nelson LM. The time is now for a newapproach to primary ovarian insufficiency. Fertil Steril 2010;95:1890-1897.
14. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. FragileXpremutation screening in women with premature ovarian failure. Hum Reprod 1998; 13:1184-1187.
15. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606.
16. Cramer DW, Xu H, Harlow BL. Family history as a predictor of early menopause. Fertil Steril 1995;64:740-745.
17. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001;27:159-166.
18. de Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010; 376:911-921.
19. Ennis S, Ward D, Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet 2006;14:253-255.
20. Fridovich-Keil JL, Gubbels CS, Spencer JB, Sanders RD, Land JA, Rubio-Gozalbo E. Ovarian function in girls and women with GALT-deficiency galactosemia. J Inherit Metab Dis 2011;34:357-366.
21. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG Jr, Warren ST et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-1058.
22. Garcia-Arocena D, Hagerman PJ. Advances in understanding the molecular basis of FXTAS. Hum Mol Genet 2010;19:R83-R89.
23. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Mullerian hormone. Fertil Steril 2009;91:1700-1706.
24. Gleicher N, Weghofer A, Barad DH. Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertilewomenand egg donors. Reprod Biomed Online 2010;20:485-491.
25. Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol 2012;10:77.
26. Ishizuka B, Okamoto N, Hamada N, Sugishita Y, Saito J, Takahashi N, Ogata T, Itoh MT. Number of CGG repeats in the FMR1 gene of Japanese patients with primary ovarian insufficiency. Fertil Steril 2011; 96:1170-1174.
27. Janse F, Knauff EA, Niermeijer MF, Eijkemans MJ, Laven JS, Lambalk CB, Fauser BC, Goverde AJ; Dutch Premature Ovarian Failure Consortium. Similar phenotype characteristics comparing familial and sporadic premature ovarian failure. Menopause 2010;17:758-765.
28. Karimov CB, Moragianni VA, Cronister A, Srouji S, Petrozza J, Racowsky C, Ginsburg E, Thornton KL, Welt CK. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod 2011;26:2077-2083.
29. Knauff EA, Westerveld HE, Goverde AJ, Eijkemans MJ, Valkenburg O, van Santbrink EJ, Fauser BC, van der Schouw YT. Lipid profile of women with premature ovarian failure. Menopause 2008;15:919-923.
30. Kronquist KE, Sherman SL, Spector EB. Clinical significance of tri-nucleotide repeats in Fragile X testing: a clarification of American College of Medical Genetics guidelines. Genet Med 2008;10:845-847.
31. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003;18:199-206.
32. Mattei MG, Mattei JF, Ayme S, Giraud F. X-autosome translocations: cytogenetic characteristics and their consequences. Hum Genet 1982; 61:295-309.
33. Morris DH, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Familial concordance for age at natural menopause: results from the Breakthrough Generations Study. Menopause 2011;18:956-961.
34. Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 1998; 35:637-640.
35. Nolin SL, Brown WT, Glicksman A, Houck GE Jr, Gargano AD, Sullivan A, Biancalana V, Bröndum-Nielsen K, Hjalgrim H, Holinski-Feder E et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 2003;72:454-464.
36. Oktay K, Kim JY, Barad D, Babayev SN. Association ofBRCA1mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol 2010; 28:240-244.
37. Oostra BA, Willemsen R. Afragile balance: FMR1expression levels. HumMol Genet 2003;12:R249-R257.
38. Otsuka S, Sakamoto Y, Siomi H, Itakura M, Yamamoto K, Matumoto H, Sasaki T, Kato N, Nanba E. Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain Dev 2010;32:110-114.
39. Peprah E. Fragile X syndrome: the FMR1 CGG repeat distribution among world populations. Ann Hum Genet 2012;76:178-191.
40. Peprah E, He W, Allen E, Oliver T, Boyne A, Sherman SL. Examination of FMR1 transcript and protein levels among 74 premutation carriers. J Hum Genet 2010;55:66-66.
41. Rossetti R, Di Pasquale E, Marozzi A, Bione S, Toniolo D, Grammatico P, Nelson LM, Beck-Peccoz P, Persani L. BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Hum Mutat 2009;30:804-810.
42. Schuettler J, Peng Z, Zimmer J, Sinn P, von Hagens C, Strowitzki T, Vogt PH. Variable expression of the Fragile?Mental Retardation 1 (FMR1) gene in patients with premature ovarian failure syndrome is not dependent on number of (CGG)n triplets in exon 1. Hum Reprod 2011;26:1241-1251.
43. Seltzer MM, Baker MW, Hong J, Maenner M, Greenberg J, Mandel D. Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Am J Med Genet B Neuropsychiatr Genet 2012; 159:589-597.
44. Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 2000;97:189-194.
45. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med 2005;7:584-587.
46. Streuli I, Fraisse T, Ibecheole V, Moix I, Morris MA, de Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril 2009;92:464-470.
47. Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas 1981; 3:249-264.
48. van Asselt KM, Kok HS, Pearson PL, Dubas JS, Peeters PH, Te Velde ER, van Noord PA. Heritability of menopausal age in mothers and daughters. Fertil Steril 2004;82:1348-1351.
49. van Kasteren YM, Hundscheid RD, Smits AP, Cremers FP, van Zonneveld P, Braat DD. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod 1999;14:2455-2459.
50. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-914.
51. Voorhuis M, Onland-Moret NC, Fauser BC, Ploos van Amstel HK, van der Schouw YT, Broekmans FJ. The association of CGG repeats in the FMR1 gene and timing of natural menopause. Hum Reprod 2013;28:496-501.
52. Weghofer A, Tea MK, Barad DH, Kim A, Singer CF, Wagner K, Gleicher N. BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n, 26) FMR1 sub-genotypes: explanation for the BRCA paradox? PLoS One 2012;7:e44753.
53. Willemsen R, Levenga J, Oostra BA. CGG repeat in the FMR1 gene: size matters. Clin Genet 2011;80:214-225.
54. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. The FMR1 premutation and reproduction. Fertil Steril 2007;87:456-465.